KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Interest Expenses: 2009-2025

Historic Interest Expenses for Dynavax Technologies (DVAX) over the last 13 years, with Sep 2025 value amounting to $1.6 million.

  • Dynavax Technologies' Interest Expenses fell 3.30% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 1.53%. This contributed to the annual value of $6.8 million for FY2024, which is 0.55% up from last year.
  • Dynavax Technologies' Interest Expenses amounted to $1.6 million in Q3 2025, which was up 0.12% from $1.6 million recorded in Q2 2025.
  • Dynavax Technologies' Interest Expenses' 5-year high stood at $4.7 million during Q1 2021, with a 5-year trough of $1.6 million in Q2 2025.
  • For the 3-year period, Dynavax Technologies' Interest Expenses averaged around $1.7 million, with its median value being $1.7 million (2025).
  • Its Interest Expenses has fluctuated over the past 5 years, first slumped by 65.06% in 2021, then increased by 0.71% in 2024.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Interest Expenses stood at $1.7 million in 2021, then increased by 0.30% to $1.7 million in 2022, then grew by 0.48% to $1.7 million in 2023, then climbed by 0.71% to $1.7 million in 2024, then fell by 3.30% to $1.6 million in 2025.
  • Its Interest Expenses stands at $1.6 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.7 million for Q1 2025.